A multi-omics computational framework identifies cell-type-specific therapeutic targets and active compounds of Tripterygium wilfordii Hook.f. against diabetic kidney disease.
Diabetic kidney disease (DKD) is a leading cause of chronic and end-stage kidney disease, and current therapies leave patients at high risk. Tripterygium wilfordii Hook.f. (TWHF), a traditional Chinese medicine, reduces proteinuria in DKD, but the compounds and molecular targets responsible remain poorly defined. We hy...